ACHL

ACHL


A Deep Dive into Statin Therapy for HIV-infected Individuals

In this text-based interview, Dr. Hsue and Dr. Drozd discuss statin therapy in HIV-infected individuals. Discussion topics include lipid targets and guidelines recommendations, preventing drug-drug interactions, and managing potential adverse events. The faculty will also discuss the ongoing REPRIEVE clinical trial that is investigating the use of statin therapy to prevent vascular events in HIV...
ACHL

Advances in the Multidisciplinary Management of Hepatocellular Carcinoma (HCC): Strategies for Incorporating Emerging Immunotherapy Treatment Options

Expert faculty, Richard Finn, MD, discusses treatment options and strategies in a case-based approach for two patients who have failed conventional therapies and may be candidates for immunotherapy. The activity features an online virtual patient platform that affords clinicians an opportunity to absorb relevant clinical and evidence-based information. The purpose of the activity is to inform cl...
ACHL

Clinical Strategies for Incorporating Immunotherapy in Advanced Breast Cancer: Insights for Surgeons and Oncologists

Six expert faculty discuss advances in immunotherapy as it relates to breast cancer. This interview-style format is based on follow-up coverage from the “Immunotherapy and Breast Cancer” symposium at the Society of Surgical Oncology 2018 Annual Cancer Symposium, held on March 23, 2018 in Chicago, Illinois. PowerPoint slides from the symposium, as well as a written transcript of the interview...
The Academy for Continued Healthcare Learning (ACHL) and Society of Surgical Oncology (SSO)

Examining Recent Evidence Supporting DOAC Use in the Reduction of Thrombotic Events in Diverse Cardiovascular Patients

In this clinical commentary, a panel of three faculty experts review clinical data on the use of DOACs for vascular protection in patients with cardiovascular disease. The discussion will provide an in-depth analysis of safety and efficacy data on prophylactic DOAC use for reducing and/or preventing thrombotic events in patients with atherosclerotic disease. The discussion will also examine rece...
Indiana University School of Medicine

From Psoriasis to Psoriatic Arthritis: Incorporating Advances to Individualize Treatment

Drs. Kenneth B. Gordon and Alexis Ogdie-Beatty facilitate a critical review and discuss up-to-date data impacting psoriasis and psoriatic arthritis (PsA) at the point of care. This activity is intended for dermatologists, rheumatologists, primary care physicians, nurse practitioners, pharmacists, and other affiliated providers involved in the diagnosis and treatment of patients with psoriasis...
ACHL/Purdue University College of Pharmacy

IDA in Inflammatory Bowel Disease: Pathology, Treatment Options, and the Risks of Underdiagnosis.

This activity will discuss the unique clinical relationship between inflammatory bowel disease (IBD) and iron deficiency anemia (IDA), including the role IBD pathology plays in blocking optimal iron absorption. Many IBD patients contend with multiple challenges and comorbidities that all can directly or indirectly lead to IDA and subsequent poor outcomes. A leading gastroenterologist will discus...
ACHL

IDA Pathology, Etiology, and the Role of Hepcidin Across At-Risk Patient Populations

Iron-deficiency anemia is a widespread condition affecting multiple patient populations, which can range from elderly patients and women of childbearing age to cancer patients, chronic kidney disease patients, and persons with gastroenterological conditions such as IBD, among others. IDA also affects populations not traditionally screened for iron deficiency, such as those with certain cardiovas...
ACHL

Insights on the 2017 IDSA/SHEA Clinical Practice Guidelines for Clostridium difficile Infection in Adults: Focus on Recurrence

In this text-based interview, Dr. Paul Feuerstadt reviews the updated 2017 IDSA/SHEA clinical practice guidelines for the treatment of C. difficile, with a focus on recurrent infection. Upon completion of this activity, participants will be able to: • Outline risk factors for recurrent C. difficile infection to consider when selecting treatment • Discuss available data on the treatment...
ACHL

Office-Based Infusions Toolkit: A Setup Guide for Your Practice

Do you want to improve immunology care outcomes, increase medication compliance rates, grow your practice, and improve your relationship with patients? If so, then an in-house infusion clinic might be right for you and your patients. View this detailed, yet simple practice-setup guide for: - Business and financial planning templates - Infusion pricing and reimbursement information...
ACHL

Preventing Infant Morbidity & Mortality: Identifying Gaps in Nutrition Protocols

The purpose of this activity is to educate clinicians across multiple disciplines on how to recognize inadequate breast milk production (also known as “lactation failure”) and the risks it poses to both infants and mothers. While exclusively breastfeeding newborns is the gold standard of infant nutrition, exclusive nursing can pose risks to infants when breastmilk supply is inadequate; moreo...
ACHL

Primary Prevention Strategies for HIV-related Cardiovascular Disease

The use of ART prolongs survival and reduces CVD risks in HIV-infected individuals. However, the HIV-infected population also has high rates of traditional CVD, such as dyslipidemia. Clinicians must be familiar with available data to manage these risks and formulate preventive approaches. This educational activity is designed for cardiologists, infectious disease specialists, primary care phy...
ACHL

Progress in the Reversal of DOACs in Emergent Medical Situations

In this activity, a three-faculty panel of experts discuss clinical situations with emergent needs for direct oral anticoagulant (DOAC) reversal. Faculty are featured via a video-recorded conference, complete with an accompanying PowerPoint presentation. This virtual forum provides an objective, non-judgmental review of adverse DOAC outcomes and systematic process changes regarding situations wh...
ACHL

Recurrent C. difficile Infection: Expert Perspectives on Impacting Clinical Outcomes and Economics

This CME activity addresses the management of recurrent Clostridium difficile infection (CDI), including identification of at-risk patients, evidence-based treatment, and its economic impact. In this text-based interview, two faculty will discuss their approaches to the prevention and management of recurrent CDI. This is the second in a series of five educational activities on CDI to be released...
ACHL

Strategies for Preventing HIV-related Cardiovascular Disease

This text-based interview is the first of a four-part series. Dr. Chris Longenecker and Dr. Turner Overton address CVD risks in HIV-infected individuals, such as contributing factors for CVD (inflammation and immune activation), the impact of antiretroviral drug treatment (ART), risk factor modification, and ongoing clinical trials. HIV-infected individuals have an increased risk of CVD. Res...
ACHL

The Challenges of Invasive Fungal Infections in Community Hospitals: A CME Guidebook to Improve Therapy and Clinical Outcomes

This interactive digital guidebook addresses the unique challenges of the community hospital to aid community practitioners, emergency-department physicians, critical-care physicians, hematologists, oncologists, and transplant surgeons in the treatment of patients with invasive fungal infections (IFIs), particularly in immunocompromised or immunosuppressed patients. Chapter topics include the ep...
ACHL

The Multidisciplinary Assessment and Management of CVD Risk in HIV Infection

This text-based interview is the second of a four-part series. Dr. Priscilla Hsue and Dr. E. Turner Overton discuss the multidisciplinary management of CVD risk in HIV-positive individuals. Discussion topics include risk assessment tools, and collaboration across the care team, including the role of PCPs and specialist referrals. HIV-infected individuals have an increased risk of CVD. Resea...
ACHL

Therapy Selection in HIV-infected Patients with CVD Risks: A Case-based Discussion

In this case-based discussion, Dr. Longenecker and Dr. Okeke discuss therapy selection for HIV-positive individuals at-risk for CVD. Topics include the importance of early initiation of ART, selecting ART for HIV-positive individuals with dyslipidemia, considerations for viral suppression in the setting of CVD risk factors, and ongoing clinical trials. This is the third activity of a four-part s...
ACHL

Translating Recent Research into Clinical Decisions for C. difficile: Selection of Therapy

In this text-based interview, Dr. Sahil Khanna will review recent published studies and data from national meetings that may impact selection of therapy for C. difficile and its recurrence. In addition to his own research, Dr. Khanna will review highlights from IDWeek 2017, ACG2017, and the International C. diff. Awareness Conference and Health EXPO. This is the fourth in a series of five CME ac...
ACHL

Updates in the Treatment and Prevention of C. difficile: Hospital Perspectives

This CME activity addresses hospital perspectives on C. difficile infection such as surveillance, preventive strategies and tailoring therapy to disease severity and patient factors. In this video-based interview, two faculty will discuss their approaches to the prevention and management of CDI and recurrent CDI in the hospital setting. This is the third in a series of five educational activitie...
ACHL

Updates in the Treatment of C. difficile Infection: Faculty Insights

This CME activity addresses recent developments in the treatment and prevention of Clostridium difficile infection (CDI) and its recurrence. In these video-based interviews, two faculty discuss the clinical implications of recently released data on the management of CDI. This is the first in a series of five educational activities on CDI to be released in 2017. Clostridium difficile infectio...
ACHL

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.